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Background
Individuals with alcohol dependence often die prematurely [1,2]. 
Scotland in particular has high rates of alcohol misuse compared to the 
rest of the UK and Europe [3] and it imposes a substantial burden on 
Scottish society, costing between £2,475.6 million and £4,635.4 million 
per year (at 2007/2008 prices) [4]. Scotland’s death rate from chronic 
liver disease and cirrhosis are around twice as highas those in England 
and Wales and the alcohol-related death rate for women in Scotland 
exceeds the comparable rate for men in England [5]. Whilst indicators 
of alcohol-related harm are reducing in countries within Europe [6], 
in Scotland, there is little evidence to suggest a change in this trend. 
Over the five-year period 2005/06 to 2009/10 the rate of alcohol-
related discharges from psychiatric hospitals in Scotland has remained 
the same [5] and the economic impact of this to psychiatry alone is 
vast. In Scotland in 2007/2008 the cost of psychiatric bed days wholly 
attributable to alcohol was estimated at £39.6 million [4].
Although alcohol use is found across the whole of society, there 
is a clear socioeconomic trend- with individuals living within the 
most deprived areas being more likely to experience significant health 
problems due to their alcohol misuse. In Scotland in 2009/10 the 
rate of alcohol-related discharges from psychiatric hospitals were 8.5 
times greater for patients living in the most deprived areas compared 
to the most affluent areas [5]. A similar pattern too is seen for acute 
admissions where in 2011 the rate of alcohol-related discharges from 
general acute hospitals were 7.6 times greater for patients living in the 
most deprived areas compared to the least deprived areas [4].
Many studies have looked at the excess mortality associated with 
alcohol dependence- with some estimates of an increase in mortality 
rate of around 2-5 times that of age and sex matched general population 
controls [2,7,8]. However few studies have looked specifically at 
the mortality of patients admitted electively to a psychiatric ward 
for inpatient alcohol detoxification. Here we describe the clinical 
characteristics of a series of 28 deceased patients who were admitted to 
inpatient psychiatry electively for alcohol detoxification. We will also 
compare the age, sex, socioeconomic status, psychiatric comorbidity 
and estimated weekly units of alcohol of the deceased group with those 
surviving. 
Materials and Methods
We identified a deceased cohort of patients aged 16 to 65, who were 
admitted to Ward 2 at Wishaw General Hospital for elective alcohol 
detoxification under the care of one specific Addictions Consultant 
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Abstract
Background: Individuals with alcohol dependence often die prematurely. Scotland in particular has high rates of 
alcohol misuse compared to the rest of the UK and Europe. Although there is some evidence that rates of alcohol-
related harm and alcohol-related deaths are reducing in Europe, there is little evidence of this trend occurring in 
Scotland. Inpatient detoxification is an important, but expensive, option in the management of alcohol dependence. 
Little work has been done with regard possible clinical characteristics associated with mortality post discharge in this 
cohort of patients. 
Methods: Retrospective electronic records were used to identify patients admitted electively for alcohol 
detoxification into a psychiatric ward in a district general hospital under the care of a single consultant addiction 
psychiatrist between 1/1/05 and 31/12/07 inclusively. Demographic and clinical factors were recorded. 5-year 
mortality data was obtained by linkage to the National Records of Scotland.
Results: 25.2% of patients admitted for elective alcohol detoxification died during the 5-year follow up period. 
42.9% of deaths (n=12) were due to alcoholic liver disease, one death (3.6%) was of undetermined intent. A higher 
proportion of the deceased cohort was likely to have continued disulfiram (93% vs. 80%) and acamprosate (81% 
vs. 60%) than those surviving. There was no statistically significant difference in survival between individuals on 
medication and those not on medications in our cohort. The average consumption of units of alcohol per week in 
the deceased cohort was significantly higher than that calculated for the surviving cohort (298.8 units vs. 233.3 units 
p=0.0137).
Conclusion: Inpatient detoxification was associated with significant mortality at 5-year follow up post- discharge. 
The majority of deaths were due to liver disease while deaths due to accidents and of undetermined intent were 
relatively infrequent. Increased education and practical strategies such as “space and pace” aimed both at an 
individual and societal level to reduce alcohol consumption may help to reduce mortality associated with alcohol 
dependence post inpatient detoxification.
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between 1/1/05 and 31/12/07 inclusively. A number of clinical and 
demographic factors surrounding the admission including- age on 
admission, duration of admission, mental health act use, socioeconomic 
deprivation quintile, discharge medication and weekly consumption of 
units of alcohol were recorded. ICD 10 diagnoses were reviewed using 
the electronic records by JL, AM or PS and any secondary diagnoses 
were also coded. Weekly consumption of alcohol was obtained from 
the electronic records. Units per week were calculated from the 
highest consistently documented recording of alcohol intake. We also 
determined the number of patients who were recommended to be on 
disulfiram and acamprosate. It was possible to identify those who were 
likely to have discontinued the drug at an early stage (only one record 
suggesting staring the medication and no reference in subsequent 
records) and those who were likely to have continued their disulfiram or 
acamprosate (2 or more records showing that the prescription of these 
medications was still being supported by the specialist or addiction care 
team).
Date and cause of death was obtained from the National Records of 
Scotland. Cause of death was coded using the ICD10 diagnostic codes 
available on the General register for Scotland Website [9]. The study 
was registered with NHS Lanarkshire’s Clinical Quality Services.
Results
From a cohort of 111 patients who were admitted for elective 
alcohol detoxification during our study period 25.2% of patients died 
(n=28) during our 5-year follow up. 9 were female (25.7%) and 19 male 
(25.0%). Mean age at death for the cohort was 43.8 years. In women 
mean age of death was 44.6 years compared to 43.4 years for males 
(Table 1). 42.9% of deaths (n=12) were due to alcoholic liver disease 
(K70). A further 2 deaths (7.1%) were due to mental and behavioural 
disorder due to dependence on alcohol (F10), 3 deaths (10.7%) were 
due to mental and behavioural disorder due to dependence on opiates 
1 (3.1%) was due to accidental poisoning of undetermined intent (Table 2).
The average age of the deceased cohort on admission was 40.9 
years compared to 38.4 years in those surviving. Rates of comorbid 
antidepressant and antipsychotic prescription were similar between 
the deceased and surviving cohorts (Table 2). Median duration of 
admission for both the deceased and surviving cohorts was similar at 
10 and 11 days respectively (Table 2). In both cohorts, those from the 
most deprived quintile were over-representative making up more than 
50% of the population (Table 2).
Rate of comorbid polysubstance misuse was higher in the surviving 
cohort (39.8%) compared to the deceased cohort (28.6%) (Table 2). The 
most common comorbid illicit substance misused was heroin. 
A higher proportion in the deceased cohort was likely to have 
continued disulfiram (93% vs. 80%) and acamprosate (81% vs. 60%) 
although this did not reach statistical significance. The proportion 
continuing both disulfiram and acamprosate was higher in the 
surviving cohort (36% vs. 29%) although this also did not reach 
statistical significance.
In the deceased cohort the average consumption of units of alcohol 
per week was 298.8 units which was significantly higher than that 
calculated for the surviving cohort at 233.3 units. (p=0.0137) (Table 3).
In women, mean consumption of units of alcohol per week in 
both the deceased and surviving cohorts was lower than that in men 
(Figure 1). There was also a reduction in mean consumption of units of 
alcohol per week in those surviving compared to those deceased by sex 
(Figure 1). This was statistically significant in men (245.7 units/week in 
surviving men vs. 320.2units/week in deceased men p=0.0316). 
Discussion
In recent years the focus has been to promote community-based 
treatments rather than hospital-based treatments for all mental illness 
[10] and indeed for the treatment of alcohol or substance misuse 
disorders [11]. However in-patient psychiatric care remains an essential 
although expensive treatment option. In particular in-patient alcohol 
detoxification remains necessary for a significant proportion of patients 
due to specific medical indications and associated risks [11,12]. Those 
admitted for in-patient detoxification are generally at high risk of 
medical morbidities such as seizures, DTs, malnutrition and liver disease 
[11] and are generally deemed unsuitable for community detoxification. 
In our cohort of patients admitted for an elective alcohol detoxification 
one quarter died (25.2%) within the 5-year follow up period. This is 
comparable to a 4 year mortality rate of 24.0% described by Moors et 
al. in a cohort of late middle aged and older substance abuse patients 
[13]. In Germany a study looking at the mortality rate of individuals 
with alcohol dependence found that “inpatient specialised alcohol 
dependence treatment did not seem to have a sufficient protective 
effect against dying prematurely [8].” They also found a mortality rate 
of 50% in those who had participated in alcohol detoxification inpatient 
treatment at 14-years follow-up. However to our knowledge this is the 
only study specifically reviewing the clinical characteristics of deceased 
individuals admitted to inpatient psychiatry for alcohol detoxification.
In terms of cause of death 42.9% died of alcohol-related liver 
disease and 7.2% of mental and behavioural disorder due to alcohol, 
representing approximately half of our cohort.Our finding of only 
Surviving 
Detoxes
(n=83)
Deceased 
Detoxes
(n=28)\
Male (n, %) 57 (68.7%) 19 (67.9%)
Mean Age at admission
[95% C.I.]
38.4
[36.4-40.9]
40.9
[37.4-44.3] p=0.323
Mean Age at death females 95% 
CI
Mean Age at death males 95% CI
44.6 [36.5-52.8]
43.4 [39.5-47.2] p=0.7234
Detained under the Mental Health 
Act 0 (0%) 1 (3.6%)
Median duration of stay days, 
[range] 10 (1-29) 11 (1-66)
Rate from most deprived quintile
(n, %)
42 (56.8%)
(42/74) 15 (53.6%) p=0.772
Co morbid antidepressant use 17 (20.5%) 6 (21.4%) ns
Co morbid antipsychotic use 6 (7.2%) 2 (7.1%) ns
Co morbid illicit Substance misuse 33 (39.8%) 8 (28.6%) p=0.308
Disulfiram
Suggested for 
commencement 45 (54%) 13 (46%)
nsLikely early 
discontinuation 9 (20%) 2 (7%)
Likely continuation 36 (80%) 11 (93%)
Acamprosate
Suggested for 
commencement 47(57%) 16 (57%)
nsLikely early discontinuation 19 (40%) 3 (19%)
Likely continuation 28 (60%) 13 (81%)
Disulfiram & Acamprosate likely 
continued 30 (36%) 8 (29%)
ns
Table 1: Clinical & demographic factors of surviving & deceased patients who 
underwent detoxification.
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one death being of undetermined intent is suggestive of a lower than 
expected rate of suicide. This finding is surprising given the relationship 
of alcohol dependence with suicide [14] and that severe mental illness- 
including severe depression, psychosis and indeed suicidality [8] are all 
indications for inpatient detoxification. However our small sample size 
may be a possible explanatory factor for this finding.
In our cohort the mean age of death following admission for 
detoxification was for 43.4 years for males and 44.6 years for females. 
During the equivalent time period, life expectancy in the district 
(North Lanarkshire) was 74.3 year for males and 78.8 for females. It is 
well recognised that major mental illness is associated with reduced life 
expectancy [15-17] and Chang et al. [18] reported a reduction in life 
expectancy of 13.6 years for men and 14.8 years for women in the UK 
who have substance misuse disorders. Our findings of a reduction in 
life years of over 30 years, likely reflects the severity of illness in these 
individuals given the pre-requisite for inpatient detoxification and 
may be amplified by the small sample size. Nevertheless this finding of 
significant premature mortality is a public health concern. 
The debate around the effectiveness of disulfiram and acamprosate 
on long-term survival in alcohol dependence continues. Predicting 
who will respond best to acamprosate is difficult leading to some 
authors stating that ‘acamprosate should be considered for everyone 
with alcohol dependence’ [19]. Although clinical trials have been more 
conservative in terms of effectiveness [20], routine clinical practice 
and economic analysis [21] supports the use of acamprosate when 
tailored to specific patients and their treatment plans. More recently 
there has been some evidence that certain genotypes respond better to 
acamprosate and in the future pharmacogenomics may play a role in 
identifying such individuals [22]. Our study showed that around half 
of all patients were at least considered for disulfiram or acamprosate. 
Of those considered, a greater proportion in the deceased cohort was 
estimated to have continued their medications. This supports, with a 
degree of caution due to the small numbers in our specific study, the 
position that long-term mortality outcomes may not be affected by 
being considered for or being on either disulfiram or acamprosate. It 
is interesting to note that despite the suggestion, prescription, use or 
likely continuation of disulfiram the deceased cohort still claimed to 
have to have achieved a higher mean consumption of almost 300 units 
of alcohol per week.
Our study showed an association between mean maximal weekly 
alcohol consumption (expressed as units per week) and mortality rate. 
Those who died within the five year period following admission for 
detoxification reported that they drank on average, 65 units per week 
more than the surviving cohort. This relationship of increased alcohol 
consumption and increased mortality has been shown elsewhere by 
Breslow and Graubard [23] who reported that men who consumed 
more than five drinks per day (compared to those who consumed only 
one) had an adjusted relative risk of mortality of 1.30 for cardiovascular 
disease (95% confidence interval (CI) 0.96-1.75), 1.53 for cancer (95% 
CI 1.11-2.09) and 1.42 for other causes of death (95% CI 1.08-1.87). In 
women they reported an adjusted relative risk of mortality of 2.88 for 
other causes of death (95% CI 1.61-5.12). 
Our study’s findings however have a number of limitations. As 
with all retrospective case note reviews there is the possibility of bias 
in data collection which is further compounded by particular problems 
associated with the reporting of alcohol consumption. It is widely 
recognised that there may be a general under-estimation of self-reported 
alcohol consumption [24] by patients and this may have impacted on 
the results seen. Furthermore, we estimated alcohol consumption by 
documenting the maximal exposure to alcohol consistently recorded 
in the notes and converting to units/week. Although this does not 
necessarily reflect total or lifetime alcohol consumption it was felt to be 
the most reliable method of accurately recording alcohol consumption 
in this cohort. A further limitation of our data was the small sample 
size of our cohort. Other individuals who may have undergone alcohol 
detoxification in our hospital within our study timeframe, likely 
through an emergency admission were excluded. Given the likely small 
numbers and heterogeneity of the emergency admissions we included 
only individuals who received a planned alcohol detoxification under 
the care of one specific Consultant Addiction Psychiatrist.
Cause of Death n, (percentage)
Alcohol Related Liver Disease 12 (42.9%)
Mental & Behavioural Disturbance due to dependent use of 
alcohol 2 (7.1%)
Mental & Behavioural Disturbance due to dependent use of 
opioids 3 (10.7%)
Accidental Deaths 2 (7.1%)
Malignancy 2 (7.1%)
Infective (pneumonia or meningitis) 2 (7.1%)
IHD 1 (3.6%)
Poisoning of undetermined intent 1 (3.6%)
Other (Gastrointestinal haemorrhage, Thrombophlebitis 
&Cholecytsitis 2 (7.1%)
Table 2: Causes of death.
Surviving Detoxes
(n=83)
Deceased Detoxes
(n=28)
Mean weekly alcohol 
intake 95% CI
233.3
[209.4-257.2]
298.8
[241.0-356.5]
p=0.0137
Mean weekly alcohol 
intake men
95% CI
245.7
[214.0-277.5]
320.2
[244.6-395.7]
p=0.0316
Mean weekly alcohol 
intake women
95% CI
209.2
[176.2-242.2]
253.6
[155.3-351.8] p=0.234
Table 3: Average weekly alcohol intake in units documented in electronic records.
 
Surviving
Deceased
Figure 1: Average weekly alcohol intake in units documented in electronic 
records.
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The Scottish Government has recently moved forward with the 
proposal for minimum pricing of alcohol [25]. This has been shown to 
be effective in high income [26,27] countries as well as in low income 
countries [28] to reduce the harm from alcohol. In Scotland and in 
particular the West of Scotland which has high mortality rates and 
high rates of poverty compared to the rest of the UK [29], there remain 
concerns that such a pricing strategy may affect the poorest sections of 
society the hardest. This may be of clinical importance given that in our 
study more than half of the population were from the most deprived 
quintile. However, clearly strategies aimed at reducing alcohol-related 
deaths across the whole of society should be considered as potentially 
beneficial.
In Scotland the number of deaths related to excessive alcohol 
consumption outweighs those related to drug misuse- in 2011 there 
were 1,247 alcohol-related deaths [30] compared to 584 drug related 
deaths [31]. However the resources available for recording deaths due 
to drug misuse appear to be more comprehensive [32]. Currently in 
Scotland we have the National drug-related deaths data collection form 
which is completed by clinicians involved in the care of individuals with 
drug related problems prior to death. Once completed this data is then 
entered into the National Drug Related Deaths Database (NDRDD) 
from which an annual report can be generated. The report collects and 
analyses all drug related deaths on a national level and subsequently 
can give advice on prescribing and other important clinical issues to 
clinicians. Currently there is no equivalent database for alcohol-related 
deaths and so one challenge for us as health care professionals may be 
to develop detailed recording databases for alcohol-related deaths. A 
comparable resource for alcohol-related deaths may provide specific 
information on causal factors and help in preventing deaths in this 
particular population. 
Given the burden of physical and psychiatric illness associated with 
alcohol misuse combined with the huge economic cost attributed to 
its use, clinicians, researchers and policy makers should to continue 
to work together to further develop strategies aimed at reducing the 
mortality associated with alcohol misuse. Education and practical 
strategies such as “pace and space”, the use of tracker cards and setting 
of low risk limits should be encouraged to promote safe drinking [33]. 
However strategies specifically targeted to those who have recently been 
discharged from inpatient detoxification may be especially beneficial at 
reducing mortality. 
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